Abstract:Cryptococcal meningitis, mainly caused by Cryptococcus neoformans/gattii species complexes, is a lethal infection in both immunosuppressive and immunocompetent populations. We characterized 110 Cryptococcus strains collected from Xiangya Hospital of Central South University in China during the 6-year study period between 2013 and 2018, and performed their antifungal susceptibility testing. Furthermore, the clinical features, laboratory and imaging data, treatment strategies and outcomes of the subjects were retrospectively analyzed. Of 110 Cryptococcus strains, C. neoformans species complexes accounted for 96.4% (106/110), including C. neoformans sensu stricto (VNI molecular type, 95.5%, 105/110) and Cryptococcus deneoformans (VNIV molecular type, 0.9%, 1/110), and Cryptococcus deuterogattii (VGII molecular type) accounted for 3.6% (4/110). The strains were further classified into 17 individual sequence types (STs) by using multilocus sequence typing (MLST). 89.1% (98/110) were represented by ST5; seven C. deuterogattii strains and one Cryptococcus deneoformans strain were assigned as ST7 and ST260, respectively. Antifungal minimal inhibitory concentrations above the epidemiological cutoff values (ECVs) were found mainly in C. neoformans species complexes strains (nine for amphotericin B, nine for fluconazole and seven for 5-fluorocytosine). Furthermore, 60.9% (67/110) of the subjects were male, and 40.0% (44/110) did not have underlying diseases. Hepatic diseases (hepatitis/HBV carrier status and cirrhosis) were the most common underlying health conditions (11.8%, 13/110), followed by autoimmune disorders (10.9%, 12/110) and chronic kidney disease (6.36%, 7/110). Only 4.5% (5/110) of the patients were HIV/AIDS positives. For clinical presentation, headache (77.3%, 85/110), fever (47.3%, 52/110), and stiff neck (40.9%, 45/110) were commonly observed. The mortality rate was 35.0% (36/103). In conclusion, our data were characterized by a high prevalence of the Cryptococcal meningitis patients without HIV/AIDS and other underlying health conditions, a relatively high non-wild-type rate of fluconazole and amphotericin B resistance, and low genetic diversity in Cryptococcus strains. The present study will provide evidence for further improvement of the diagnosis and treatment of cryptococcosis in China.

Molecular identification of Cryptococcus gattii from cerebrospinal fluid using single-cell sequencing: A case study

Case Report: Streptococcus Suis Meningitis Diagnosed in a HIV-Infected Patient with Cryptococcal Meningitis Using Next-Generation Sequencing

Study on the diagnosis of cryptococcal meningoencephalitis by molecular biological techniques

Microbiological and Clinical Characteristics of Cryptococcemia: a Retrospective Analysis of 85 Cases in a Chinese Hospital

Antifungal susceptibility and molecular characteristics of Cryptococcus spp. based on whole-genome sequencing in Zhejiang Province, China

Metagenomic Next-generation Sequencing of Cerebrospinal Fluid for the Diagnosis of Central Nervous System Infections: A Multicentre Cohort Study

Pathogen Identification in Culture-Negative Cerebrospinal Fluid Specimens of Patients with Purulent Meningitis Using Next-Generation Sequencing Technology.

Performance of Metagenomic Next-Generation Sequencing for the Diagnosis of Cryptococcal Meningitis in HIV-Negative Patients

Clinical presentation and laboratory study for a case of cryptococcal meningitis caused by Cryptococcus gattii in Hebei province

Optimization of cerebrospinal fluid microbial DNA metagenomic sequencing diagnostics

Case Report: A Candida Meningitis in an Immunocompetent Patient Detected Through the Next-Generation Sequencing

The Feasibility of Metagenomic Next-Generation Sequencing to Identify Pathogens Causing Tuberculous Meningitis in Cerebrospinal Fluid

Microbiological, Epidemiological, and Clinical Characteristics of Patients With Cryptococcal Meningitis at a Tertiary Hospital in China: A 6-Year Retrospective Analysis

Metagenomic next-generation sequencing of cerebrospinal fluid reveals etiological and microbiological features in patients with various central nervous system infections

Metagenomic next-generation sequencing of cell-free and whole-cell DNA in diagnosing central nervous system infections

Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid for the Diagnosis of Cerebral Aspergillosis

Laboratory validation of a clinical metagenomic sequencing assay for pathogen detection in cerebrospinal fluid

Understanding Etiology of Community-Acquired Central Nervous System Infections Using Metagenomic Next-Generation Sequencing

Evaluation of Five Conventional and Molecular Approaches for Diagnosis of Cryptococcal Meningitis in Non‐hiv‐infected Patients

Molecular diagnosis of central nervous system opportunistic infections and mortality in HIV-infected adults in Central China

Data Relating to Sequencing Statistics and the Reads and Genomic Coverage Aligning to Taenia Solium in the Cerebrospinal Fluid